Current Happenings in Medicine, Research, Devices, Equipment, and Other MS Treatments
These pages contain links to top stories from a multitude of sites in that topic area. There will be a few sentences from the article first and if you want to read more there will be a ‘more’ link to redirect you to the source of the information.
For April 2017
From: National MS Society:
FDA Approves Ocrevus™ (ocrelizumab) for People with Primary Progressive MS or Relapsing MS — First Disease-Modifying Therapy for Primary Progressive MS -MORE-
From: Multiple Sclerosis Association of America: